Argenica (ASX:AGN) receives paediatric approval from FDA for infants therapeutic that aims to save lives
A Pediatric Disease Designation for Argenica’s therapeutic opens the post-clinical way for a priority review and path to market.
A Pediatric Disease Designation for Argenica’s therapeutic opens the post-clinical way for a priority review and path to market.
An ascendent Critical Metals Corp share price holds potential upside for local shareholders.
More high-grade gold intercepts confirm the modelling and offer an uplift as Matsa looks toward near-term high-grade mining.
Assays continue to come in thick and high-grade as FireFly aggressively drill away to demonstrate a world class copper-gold asset.
Top end lithium and tantalum strikes compare favourably to world class assets and offer a taste of Trieste’s tantalising potential.
C29 snaps up a Kazakhstani uranium asset under new leadership and gets ready to explore its open, high-grade foreign resource.
Lord secures a farm-in pact with lithium power Mineral Resources over its Horse Rocks asset in the heart of a lithium super province.
Altech’s DFS shows highly profitable production of its industry-disrupting battery storage technology.
Emmerson is looking toward cash flow after releasing the initial ore reserves from its large-scale Tennant Creek partnership.
A gold and lithium-focused portfolio gets put in the spotlight as players in resources discuss the upcoming potential of a commodity supercycle.